Click on this slide to view a brief introduction to ENCePP:
The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP®) is a network coordinated by the European Medicines Agency (EMA). The members of this network (the ENCePP partners) are public institutions and contract and research organisations (CRO) involved in research in pharmacoepidemiology and pharmacovigilance. Research interests are not restricted to the safety of medicines but may include the benefits and risks of medicines, disease epidemiology and drug utilisation. Participation to ENCePP is voluntary.
ENCePP aims to strengthen the monitoring of the benefit-risk balance of medicinal products in Europe by:
For more information, please see the current ENCePP work plan.
ENCePP provides a unique opportunity for collaboration to improve pharmacoepidemiological research and post-authorisation safety surveillance of medicinal products in Europe through access to a robust network of resources working in a transparent and independent manner and support to conduct joint studies. Individual centres and networks that are registered in ENCePP may be contacted directly or by submitting a request to the ENCePP Secretariat to place an announcement in the ENCePP partners forum.
Since its establishment ENCePP has produced a number of key outputs: